Georgetown University

This phase 2 trial tests whether adding a cancer vaccine (NY-ESO-1) to an immunotherapy drug (toripalimab) can prevent resistance in women with stage III or IV ovarian cancer that no longer responds to platinum chemotherapy. The study plans to enroll 24 participants and will meas…

This study tests a new way to give radiation for low to intermediate risk prostate cancer. Using MRI scans, doctors will deliver a higher radiation dose to the tumor while lowering the dose to the rest of the prostate. The goal is to control the cancer while reducing side effects…

This study tests a personalized approach to hormone therapy for men with metastatic hormone-sensitive prostate cancer. The goal is to reduce treatment intensity for lower-risk patients to minimize side effects while still controlling the cancer. About 108 participants will receiv…

This early-stage study tests whether resveratrol (JOTROL) is safe and tolerable for people with Parkinson's disease. About 30 participants will receive either a low dose, high dose, or placebo daily for 3 months. The goal is to check for side effects and measure how the drug beha…

This study looks at the best way to help prostate cancer survivors learn about and get genetic testing for inherited cancer risks. About 500 participants will be randomly assigned to a digital guide, a printed guide, or standard care. Researchers will track who requests testing a…